stock logo
BALAXI
₹50.19
+0.22 (0.44%)

Balaxi Pharmaceuticals Ltd. (BALAXI) live share price today at NSE / BSE

Overview
Charts
Results
News & Events

Expert Verdict for Balaxi Pharmaceuticals Ltd. (BALAXI) Share

View details
Today`s low
0.00
Today`s high
0.00
Today`s return
Balaxi Pharmaceuticals Ltd. (BALAXI) Share Price Today
Performance Of Balaxi Pharmaceuticals Ltd. (BALAXI) Share Today
Opening Price:50.48
Previous closing Price:49.97
Volume of Balaxi Pharmaceuticals Ltd. (BALAXI) share:6,43,996
Value of Share:50.19
Fundamental of Balaxi Pharmaceuticals Ltd. (BALAXI) Share Price
Market Capitalisation:276 Cr.
P/E Ratio:11.00
P/B Ratio:1.19
Sector P/E:66.94
EPS (TTM):4.54
Dividend Yield:0.00
14D - RSI:44.35
50 DMA:51.89
200 DMA:70.03

Note: The above data is mentioned as per the Balaxi Pharmaceuticals Ltd. (BALAXI) share price today.

Balaxi Pharmaceuticals Ltd. (BALAXI) Share Price Today At NSE

    • Live Balaxi Pharmaceuticals Ltd. (BALAXI) Share Price NSE India: ₹50.19
    • Previous Closing Price: ₹49.97
    • Open Price: ₹50.48
    • High: ₹50.54
    • Low: ₹49.93

Balaxi Pharmaceuticals Ltd. (BALAXI) Share Price Today At BSE

  • Live Balaxi Pharmaceuticals Ltd. (BALAXI) Share Price BSE India: ₹undefined
  • Previous Closing Price: ₹undefined
  • Open Price: ₹undefined
  • High: ₹undefined
  • Low: ₹undefined

Historical Price Of Balaxi Pharmaceuticals Ltd. (BALAXI) Share

The table below shows the variations in Balaxi Pharmaceuticals Ltd. (BALAXI) share price from January 2018 to July 2025.

Month & YearPrice (INR)Open Price (INR)High Price (INR)Low Price (INR)Volume (Cr.)Change %
January 201814.8514.1514.8514.157974.95
February 201814.9014.9014.9014.901000
March 201814.8014.8014.8014.8010
April 201814.8014.8014.8014.802,0200
June 201814.8014.8014.8014.80500
July 201815.4515.5015.5014.754,660-0.32
August 201830.1016.2030.1016.202,45385.8
September 201829.9529.9529.9529.9520
October 201828.5028.5028.5028.5070
January 201928.5028.5028.5028.5040
February 201928.5027.1028.5027.107155.17
March 201938.0029.9038.0029.9042227.09
April 201995.2039.9095.2039.9066,806138.6
May 201980.7599.95140.4080.751,45,724-19.21
June 201977.8577.00115.0076.9040,5101.1
July 201966.9074.0085.9060.6560,014-9.59
August 201987.0566.0092.1560.0020,58031.89
September 201990.1587.70102.0582.708,8882.79
October 201979.6086.1090.9073.1514,415-7.55
November 201978.3083.5583.5563.907,688-6.28
December 201981.2081.1090.0066.6511,7920.12
January 202081.9583.0086.9064.0552,835-1.27
February 2020102.1081.95130.9075.1072,16024.59
March 202074.00110.00116.9064.359,741-32.73
April 202073.0077.7083.5067.8519,712-6.05
May 2020109.7573.10117.4065.0514,89350.14
June 2020123.90114.50134.90102.5053,6138.21
July 2020246.75125.90246.75118.2563,01795.99
August 2020441.85259.05441.85259.053,33,03470.57
September 2020706.30463.90960.65419.8097,29552.25
October 2020831.40741.601,080.20739.751,16,68312.11
November 2020638.25829.45829.95620.0074,284-23.05
December 2020649.90638.25687.00558.7061,4361.83
January 2021527.20649.75673.95524.3053,095-18.86
February 2021540.50527.25644.00500.0096,2832.51
March 2021524.50564.40642.95510.001,44,347-7.07
April 2021584.75550.70628.00527.2048,9466.18
May 2021674.45586.15747.00557.001,19,06615.06
June 2021587.65674.45688.45558.7092,054-12.87
July 2021586.55587.70684.00575.801,43,134-0.2
August 2021543.55580.00609.00507.3060,962-6.28
September 2021571.95554.00611.00523.3051,9493.24
October 2021557.90577.45700.00500.2092,165-3.39
November 2021526.15572.95591.75512.0029,786-8.17
December 2021513.10539.00558.95447.0574,477-4.81
January 2022485.85532.90599.85425.851,08,867-8.83
February 2022420.10490.00524.80341.6564,177-14.27
March 2022351.60446.85446.85345.0062,210-21.32
April 2022444.25374.00498.10354.302,09,77718.78
May 2022414.55434.00527.50354.951,08,329-4.48
June 2022354.20414.50455.00303.5590,408-14.55
July 2022389.60361.25432.00350.2039,0097.85
August 2022578.65395.35616.60390.002,29,43846.36
November 2023418.25410.45449.80401.1058,1821.9
December 2023432.35419.20453.50404.8085,7383.14
January 2024443.25438.45455.30425.0098,3201.09
February 2024612.75441.00686.30426.158,68,91338.95
March 2024495.95617.75619.95462.402,40,151-19.72
April 2024611.50495.95619.00490.301,61,54923.3
May 2024119.00616.70734.50117.808,01,861-80.7
June 2024119.30126.00133.0093.009,62,290-5.32
July 2024120.85119.90129.44104.007,28,1340.79
August 2024107.61121.00121.3098.387,70,973-11.07
September 2024106.79108.20127.45104.4025,50,068-1.3
October 202489.95106.50107.3186.877,92,310-15.54
November 202482.1489.5092.7074.007,51,481-8.22
December 202472.3183.8085.5868.915,37,823-13.71
January 202567.9172.3184.000.0020,96,837-6.08
February 202553.3070.8672.0051.004,75,592-24.78
March 202563.9255.6576.1050.421,15,41,81814.86
April 202555.1664.9573.7054.1679,08,291-15.07
May 202549.9955.3557.9249.2023,37,454-9.68
June 202550.0251.3463.9048.731,27,31,001-2.57
July 202549.9749.7151.6148.5330,00,6490.52

Shareholding Pattern of Balaxi Pharmaceuticals Ltd. (BALAXI) Shares In Stock Market

The below depicted shareholding pattern is as per the Balaxi Pharmaceuticals Ltd. (BALAXI) Industries Ltd. Share Price Market of March 2025.

Promoters65.99%
Foreign Institutions16.02%
Retail and Others17.97%
Other Domestic Institutions0.02%
Mutual Funds0.00%
Balaxi Pharmaceuticals Ltd. (BALAXI) Share Background
Face Value2.00
ISININE618N01022
Market Lot1.00
InstrumentEQUITY
Should you invest in Balaxi Pharmaceuticals Ltd. (BALAXI) Industries Limited?
  • Every milestone results from a lot of hard work, effort, and making the correct decisions, but patience is essential.
  • Patience is the key to success in the share market, which is also important in attaining benefits on Balaxi Pharmaceuticals Ltd. (BALAXI) share price.
  • In terms of investment, the investor’s patience pays off with a high return, which is why long-term investors are the most successful.
  • Balaxi Pharmaceuticals Ltd. (BALAXI) Industries has produced a great return to the last year and is reaching new milestones daily; it has become the first Indian firm to attain a market capitalisation of 276 Cr.
  • Balaxi FAQs

    Is Balaxi Pharmaceuticals Ltd. a good stock to invest in?

    arrow

    Our expert verdict states that Balaxi Pharmaceuticals Ltd. is in Sell zone for Short term and is in Sell zone for Long term.

    Should I buy Balaxi Pharmaceuticals Ltd. share now?

    arrow

    As per our verdict, Balaxi Pharmaceuticals Ltd. is in the Sell zone for Short term.

    Should I buy Balaxi Pharmaceuticals Ltd. shares for the long term?

    arrow

    As per our verdict, Balaxi Pharmaceuticals Ltd. is in Sell zone for Long term.

    What is Balaxi Pharmaceuticals Ltd. share price today?

    arrow

    The Balaxi Pharmaceuticals Ltd. share price today is 50.19.

    How to buy Balaxi Pharmaceuticals Ltd. share?

    arrow

    You can buy Balaxi Pharmaceuticals Ltd. shares on any demat broker by completing your KYC. Before buying any stock, check BUY/SELL/HOLD insights on the Univest App.

    What is the share price of Balaxi Pharmaceuticals Ltd.?

    arrow

    The share price of Balaxi Pharmaceuticals Ltd. is 50.19, please note that the price may vary on a real-time basis.

    What is the PE and PB ratio of Balaxi Pharmaceuticals Ltd.?

    arrow

    PE ratio of Balaxi Pharmaceuticals Ltd. is 11 and PB ratio of Balaxi Pharmaceuticals Ltd. is 1.19.

    How’s PE of Balaxi Pharmaceuticals Ltd. compared to its sector?

    arrow

    PE ratio of Balaxi Pharmaceuticals Ltd. is 11 whereas the sector PE ratio is 66.94.

    What is the market cap of Balaxi Pharmaceuticals Ltd.?

    arrow

    Balaxi Pharmaceuticals Ltd.’s market cap is 276.

    What are today’s High and Low prices of Balaxi Pharmaceuticals Ltd. ?

    arrow

    Today’s High of Balaxi Pharmaceuticals Ltd. is 50.54.
    Today’s Low of Balaxi Pharmaceuticals Ltd. is 49.93.

    icon

    100% Safe & Secure Platform.

    Univest encrypts all data and transactions to ensure a completely secure experience for our members.

    Copyright

    2025 Univest. All rights reserved. | Designed with ❤️ in India
    About Univest
    About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
    Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
     
    Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
     
    Univest Stock Broking Disclosures
    Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
     Risk Disclosures on Derivatives
    1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
    2. On an average, loss makers registered net trading loss close to ₹ 50,000
    3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
    4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
    Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
    Investors are further cautioned to avoid practices like:
    a. Sharing 
    i) trading credentials – login id and passwords including OTPs.
    ii) trading strategies,
    iii) position details.
    b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
    c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
    d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
    e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
     Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
    Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
    Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
    Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
    Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
    General
    arrow down